Home

Site Search

Pipeline

Home

FB-102

CD122 is subunit of IL-2/IL-15 receptors which are key regulators of NK cells and T cell subsets
FB-102 (Forte’s anti-CD122 antibody) is designed to mediate NK and CD 8+ T cells specifically
Significant amount of proof-of-concept preclinical data supports activity of CD-122 blockade, including in GvHD and vitiligo

Home
News
About Us
Investor Relations
Management
Contact Us
Pipeline

Headquarters

Forte Biosciences, Inc.
3060 Pegasus Park Dr.
Building 6
Dallas, TX 75247

inquiry@fortebiorx.com

Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Forte Biosciences Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Forte Biosciences Inc to send you the requested Investor Email Alert updates.

* Required

Email Address *

Mailing Lists *

Press Releases
Events
Presentations
SEC Filings
End of Day Stock Quote